CN1178901C - 新的环状α-氨基-γ-羟基酰胺化合物、其制备方法和含有该化合物的药物组合物 - Google Patents

新的环状α-氨基-γ-羟基酰胺化合物、其制备方法和含有该化合物的药物组合物 Download PDF

Info

Publication number
CN1178901C
CN1178901C CNB021213909A CN02121390A CN1178901C CN 1178901 C CN1178901 C CN 1178901C CN B021213909 A CNB021213909 A CN B021213909A CN 02121390 A CN02121390 A CN 02121390A CN 1178901 C CN1178901 C CN 1178901C
Authority
CN
China
Prior art keywords
formula
compound
amino
oxo
ethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB021213909A
Other languages
English (en)
Chinese (zh)
Other versions
CN1392137A (zh
Inventor
M��ά�ձȴĻ�
M·维日比茨基
J-M·富尔凯
N·勒旺
-
B·乌松－罗勃特
O·诺西雅
M·布兰格
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratoires Servier SAS
Original Assignee
Les Laboratoires Servier SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier SAS filed Critical Les Laboratoires Servier SAS
Publication of CN1392137A publication Critical patent/CN1392137A/zh
Application granted granted Critical
Publication of CN1178901C publication Critical patent/CN1178901C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/14—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/20—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pyrrole Compounds (AREA)
CNB021213909A 2001-06-18 2002-06-18 新的环状α-氨基-γ-羟基酰胺化合物、其制备方法和含有该化合物的药物组合物 Expired - Fee Related CN1178901C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0107934A FR2826003B1 (fr) 2001-06-18 2001-06-18 Nouveaux derives cycliques d'alpha-amino-gamma-hydroxy- amides, leur procede de preparation et les compositions pharmaceutiques que les contiennent
FR0107934 2001-06-18

Publications (2)

Publication Number Publication Date
CN1392137A CN1392137A (zh) 2003-01-22
CN1178901C true CN1178901C (zh) 2004-12-08

Family

ID=8864417

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB021213909A Expired - Fee Related CN1178901C (zh) 2001-06-18 2002-06-18 新的环状α-氨基-γ-羟基酰胺化合物、其制备方法和含有该化合物的药物组合物

Country Status (24)

Country Link
US (1) US6593312B2 (https=)
EP (1) EP1270562B1 (https=)
JP (1) JP2003012642A (https=)
CN (1) CN1178901C (https=)
AR (1) AR034516A1 (https=)
AT (1) ATE277027T1 (https=)
AU (1) AU781822B2 (https=)
BR (1) BR0202313A (https=)
CA (1) CA2389858C (https=)
CZ (1) CZ20022119A3 (https=)
DE (1) DE60201296T2 (https=)
DK (1) DK1270562T3 (https=)
EA (1) EA004955B1 (https=)
ES (1) ES2229063T3 (https=)
FR (1) FR2826003B1 (https=)
HU (1) HUP0202011A3 (https=)
MX (1) MXPA02005997A (https=)
NO (1) NO322155B1 (https=)
NZ (1) NZ519610A (https=)
PL (1) PL354565A1 (https=)
PT (1) PT1270562E (https=)
SI (1) SI1270562T1 (https=)
SK (1) SK285989B6 (https=)
ZA (1) ZA200204865B (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1385508B1 (en) * 2001-03-27 2008-05-21 Merck & Co., Inc. Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122010000020I1 (de) * 1996-04-25 2010-07-08 Prosidion Ltd Verfahren zur Senkung des Blutglukosespiegels in Säugern

Also Published As

Publication number Publication date
BR0202313A (pt) 2003-04-29
EA200200574A1 (ru) 2002-12-26
EP1270562A3 (fr) 2003-05-07
CA2389858C (fr) 2007-08-28
AR034516A1 (es) 2004-02-25
ATE277027T1 (de) 2004-10-15
PL354565A1 (en) 2002-12-30
NO20022891D0 (no) 2002-06-17
ZA200204865B (en) 2003-02-20
SI1270562T1 (en) 2004-12-31
JP2003012642A (ja) 2003-01-15
DE60201296T2 (de) 2006-02-23
FR2826003B1 (fr) 2003-08-15
US6593312B2 (en) 2003-07-15
FR2826003A1 (fr) 2002-12-20
AU781822B2 (en) 2005-06-16
DE60201296D1 (de) 2004-10-28
NO20022891L (no) 2002-12-19
HUP0202011A3 (en) 2005-07-28
PT1270562E (pt) 2004-11-30
NO322155B1 (no) 2006-08-21
EP1270562B1 (fr) 2004-09-22
MXPA02005997A (es) 2005-02-17
CA2389858A1 (fr) 2002-12-18
SK285989B6 (sk) 2008-01-07
HK1050186A1 (en) 2003-06-13
AU4882202A (en) 2002-12-19
SK8772002A3 (en) 2003-01-09
EA004955B1 (ru) 2004-10-28
CN1392137A (zh) 2003-01-22
NZ519610A (en) 2003-05-30
US20030004138A1 (en) 2003-01-02
HUP0202011A2 (hu) 2003-01-28
EP1270562A2 (fr) 2003-01-02
ES2229063T3 (es) 2005-04-16
CZ20022119A3 (cs) 2003-02-12
DK1270562T3 (da) 2005-01-24
HU0202011D0 (https=) 2002-08-28

Similar Documents

Publication Publication Date Title
CN1048722C (zh) (s)(+)-2-乙氧基-4-[n-[1-(2-哌啶子基-苯基)-3-甲基-1-丁基]氨基羰基甲基]苯甲酸,含该化合物的药物组合物及其制备方法
CN1699343A (zh) 盐酸多奈哌齐的多晶型物及其制备方法
CN1538967A (zh) 杂环化合物和以其为有效成分的抗肿瘤药
HK1050357A1 (en) New -amino acid sulphonyl compounds, a process for their preparation and pharmaceutical compositions containing them
CN1109054A (zh) 噁唑烷-2-酮衍生物
CN1668585A (zh) 用作蝇蕈碱受体拮抗剂的3,6－二取代氮杂双环[3.1.0]己烷衍生物
CN87104870A (zh) 烷基取代的苯并嗪利福霉素衍生物、其制备方法及含此衍生物的抗菌剂
CN1157376C (zh) 芳基哌啶子基丙醇和芳基哌嗪子基丙醇衍生物和含有它们的药物
CN86104787A (zh) 制备聚-4-氨基吡咯-2-甲酰胺基衍生物的方法
CN1071665A (zh) 唑烷酮衍生物
CN100345834C (zh) 异羟肟酸衍生物
CN1178901C (zh) 新的环状α-氨基-γ-羟基酰胺化合物、其制备方法和含有该化合物的药物组合物
CN1721417A (zh) 新的吡咯烷和噻唑烷化合物、它们的制备方法和包含它们的药物组合物
CN1886132A (zh) 用作降压药的卡维地洛和其它β阻断剂的硝基氧基衍生物
HK1042094A1 (en) New benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
CN1113871C (zh) 9－氨基吖啶衍生物及其制备方法
CN1207282C (zh) 盐酸多奈哌齐的多晶型物（iii），其制备方法及用途
CN1245500A (zh) 新型萘啶衍生物
CN1183121C (zh) 2-(2-芳基吗啉-2-基)-乙醇和中间体的制备方法
HK1050186B (en) NEW CYCLIC α-AMINO-γ-HYDROXYAMIDE COMPOUNDS, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
CN1010779B (zh) 六氢小檗因衍生物的制备方法
CN1156446C (zh) 茚并吲哚酮化合物、它们的制备方法和含有它们的药物组合物
CN1906182A (zh) 抗高血压药物硝基氧基衍生物
CN1186318C (zh) 新的苯磺胺化合物、其制备方法以及含有它们的药物组合物
HK1042477A1 (en) New heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane compouns, a process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1050186

Country of ref document: HK

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20041208